Alzheimer Disease (immunology) < Alzheimer Disease (metabolism) < Alzheimer Disease (mortality)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000068 (1999)	L. Buée [France] ; A. Delacourte	Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease.
000139 (2000)	P. Dubus [France] ; B. Faucheux ; F. Boissière ; A. Groppi ; C. Vital ; A. Vital ; Yves Agid [France] ; E C Hirsch ; J P Merlio	Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease.
000173 (2000)	C B Lücking [France] ; A. Brice	Alpha-synuclein and Parkinson's disease.
000397 (2003)	Jose-Luis González De Aguilar [France] ; Frédérique René ; Luc Dupuis ; Jean-Philippe Loeffler	Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
000535 (2005)	Guylaine Hoffner [France] ; Philippe Djian	Transglutaminase and diseases of the central nervous system.
000607 (2006)	V. Deramecourt [France] ; S. Bombois ; C-A Maurage ; A. Ghestem ; H. Drobecq ; E. Vanmechelen ; F. Lebert ; F. Pasquier ; A. Delacourte	Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
000837 (2008)	Bruno Vincent [France] ; Moustapha Alfa Cisse ; Claire Sunyach ; Marie-Victoire Guillot-Sestier ; Frédéric Checler	Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives.
000A55 (????)	Stéphane Martin [France]	[Extranuclear functions of protein sumoylation in the central nervous system].
000A68 (1990)	R. Deloncle [France] ; O. Guillard	Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication.
000D36 (1990)	M. Ruberg [France] ; W. Mayo ; A. Brice ; C. Duyckaerts ; J J Hauw ; H. Simon ; M. Lemoal ; Yves Agid [France]	Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
000E32 (2011)	Guylaine Hoffner [France] ; Amandine Vanhoutteghem ; William André ; Philippe Djian	Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.
000E75 (2012)	Ismael Galván [France] ; Ghanem Ghanem ; Anders P. M Ller	Has removal of excess cysteine led to the evolution of pheomelanin? Pheomelanogenesis as an excretory mechanism for cysteine.
000E76 (1990)	I. Ceballos [France] ; F. Javoy-Agid ; A. Delacourte ; A. Defossez ; A. Nicole ; P M Sinet	Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency?
001024 (2012)	Marie-Hélène Canron [France] ; Martine Perret [France] ; Anne Vital [France] ; Erwan Bézard [France] ; Benjamin Dehay [France]	Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate
001514 (2014)	Mauricio G. Martín [Argentine] ; Frank Pfrieger [France] ; Carlos G. Dotti [Espagne]	Cholesterol in brain disease: sometimes determinant and frequently implicated
001752 (2015)	Ling Shan [États-Unis] ; Yves Dauvilliers [France] ; Jerome M. Siegel [États-Unis]	Interactions of the histamine and hypocretin systems in CNS disorders.
001990 (2016)	Sheela Vyas [France] ; Ana João Rodrigues [Portugal] ; Joana Margarida Silva [Portugal] ; Francois Tronche [France] ; Osborne F. X. Almeida [Allemagne] ; Nuno Sousa [Portugal] ; Ioannis Sotiropoulos [Portugal]	Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration
001C25 (????)	J L Mege [France] ; C. Capo ; B. Michel ; J L Gastaut ; P. Bongrand	Phagocytic cell function in aged subjects.
001C83 (1994)	S. Lehéricy [France] ; J P Brandel ; E C Hirsch ; P. Anglade ; J. Villares ; D. Scherman ; C. Duyckaerts ; F. Javoy-Agid ; Yves Agid [France]	Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
001C88 (1994)	A. Delacourte [France]	Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
001D21 (1993)	A. Kastner [France] ; E C Hirsch ; M T Herrero ; F. Javoy-Agid ; Yves Agid [France]	Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Alzheimer Disease (metabolism)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Alzheimer Disease (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Alzheimer Disease (metabolism)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024